DK1947104T3 - Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C - Google Patents

Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C

Info

Publication number
DK1947104T3
DK1947104T3 DK08000552.3T DK08000552T DK1947104T3 DK 1947104 T3 DK1947104 T3 DK 1947104T3 DK 08000552 T DK08000552 T DK 08000552T DK 1947104 T3 DK1947104 T3 DK 1947104T3
Authority
DK
Denmark
Prior art keywords
characterization
compositions
identification
methods
hcv
Prior art date
Application number
DK08000552.3T
Other languages
English (en)
Inventor
Carol Holland-Staley
Original Assignee
Lab 21 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab 21 Ltd filed Critical Lab 21 Ltd
Application granted granted Critical
Publication of DK1947104T3 publication Critical patent/DK1947104T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK08000552.3T 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C DK1947104T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36360302P 2002-03-11 2002-03-11
EP03714097A EP1490383B1 (en) 2002-03-11 2003-03-11 Methods and compositions for identifying and characterizing hepatitis c

Publications (1)

Publication Number Publication Date
DK1947104T3 true DK1947104T3 (da) 2012-08-06

Family

ID=28041784

Family Applications (3)

Application Number Title Priority Date Filing Date
DK03714097T DK1490383T3 (da) 2002-03-11 2003-03-11 Fremgangsmåde og sammensætning til identifikation og karakterisering af hepatitis C
DK08014584.0T DK2014671T3 (da) 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identificering og karakterisering af hepatitis C
DK08000552.3T DK1947104T3 (da) 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK03714097T DK1490383T3 (da) 2002-03-11 2003-03-11 Fremgangsmåde og sammensætning til identifikation og karakterisering af hepatitis C
DK08014584.0T DK2014671T3 (da) 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identificering og karakterisering af hepatitis C

Country Status (9)

Country Link
US (3) US20070172926A1 (da)
EP (3) EP2014671B1 (da)
AT (3) ATE423785T1 (da)
AU (2) AU2003218111B8 (da)
DE (2) DE60332781D1 (da)
DK (3) DK1490383T3 (da)
ES (3) ES2346717T3 (da)
PT (3) PT2014671E (da)
WO (1) WO2003077729A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60332781D1 (de) 2002-03-11 2010-07-08 Lab 21 Ltd Verfahren und Zusammensetzungen zur Identifizierung und Charakterisierung von Hepatitis C
AU2006235438A1 (en) * 2005-04-11 2006-10-19 Achillion Pharmaceuticals, Inc. Pharmaceutical compositions for and methods of inhibiting HCV replication
JP2009512426A (ja) * 2005-10-14 2009-03-26 イヴァン・ペテャエフ 偏性細胞内病原体の治療および診断
CN100365124C (zh) * 2005-10-27 2008-01-30 云南大学 一段丙型肝炎病毒特异性cDNA序列的应用
US20080015834A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for molecular inhibition
US20080014572A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for molecular inhibition
US20090082344A1 (en) * 2006-07-13 2009-03-26 Searete Llc Methods and systems for treating disease
EP2463390A1 (en) 2006-10-20 2012-06-13 Innogenetics N.V. Methodology for analysis of sequence variations within the HCV NS5B genomic region
EP2121991A2 (en) 2006-10-20 2009-11-25 Innogenetics N.V. Methodology for analysis of sequence variations within the hcv ns3/4a genomic region
BRPI0818488A2 (pt) * 2007-10-30 2015-04-14 Intermune Inc Genotipagem e fenotipagem de hcv
ES2361598T3 (es) * 2007-10-31 2011-06-20 Debiopharm S.A. Análisis del genoma casi completo de la resistencia a fármacos del hcv.
EP2576823A1 (en) 2010-06-04 2013-04-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Constitutively active prolactin receptor variants as prognostic markers and therapeutic targets to prevent progression of hormone-dependent cancers towards hormone-independence
WO2012177739A2 (en) * 2011-06-20 2012-12-27 Siemens Healthcare Diagnostics Inc. Reagents and methods for detecting hcv
AU2013205064B2 (en) * 2012-06-04 2015-07-30 Gen-Probe Incorporated Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
ES2012739T5 (es) 1987-11-18 2001-12-01 Chiron Corp Diagnosticos para nanbv.
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
EP0435229A1 (en) * 1989-12-27 1991-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. DNA of non-A, non-B hepatitis virus gene, its clone and use thereof
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
WO1993000365A2 (en) * 1991-06-24 1993-01-07 Chiron Corporation Hepatitis c virus (hcv) polypeptides
US20030125270A1 (en) * 2000-12-18 2003-07-03 Lawrence Blatt Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection
CA2662090A1 (en) * 1993-04-27 1994-11-10 N.V. Innogenetics S.A. New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
DE69434116T2 (de) * 1993-05-05 2005-10-27 Common Services Agency Hepatitis-c virus typ 4,5 und 6
US5571673A (en) * 1994-11-23 1996-11-05 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6242187B1 (en) * 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US7338759B1 (en) * 1997-03-04 2008-03-04 Washington University HCV variants
US6153421A (en) * 1997-07-18 2000-11-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloned genomes of infectious hepatitis C viruses and uses thereof
CA2298102A1 (en) * 1997-07-30 1999-02-11 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6280940B1 (en) * 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
ATE404698T1 (de) * 2000-04-18 2008-08-15 Virco Bvba Methode zur bestimmung der resistenz gegen medikamente
CA2409873C (en) * 2000-05-23 2013-01-08 Washington University Hcv variants
EP1373576A4 (en) * 2000-07-24 2005-06-15 Inst Of Molecul & Cell Biology NUCLEIC ACIDS AND METHODS FOR DETECTING VIRAL INFECTION, DISCOVERING CANDIDATE ANTI-VIRAL DRUGS AND DETERMINING DRUG RESISTANCE OF VIRAL ISOLATES
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
DE60332781D1 (de) 2002-03-11 2010-07-08 Lab 21 Ltd Verfahren und Zusammensetzungen zur Identifizierung und Charakterisierung von Hepatitis C

Also Published As

Publication number Publication date
AU2003218111B2 (en) 2008-11-06
EP2014671A1 (en) 2009-01-14
PT1947104E (pt) 2012-08-09
US20070172926A1 (en) 2007-07-26
EP1490383B1 (en) 2009-02-25
US20090047663A1 (en) 2009-02-19
DK1490383T3 (da) 2009-06-08
WO2003077729A2 (en) 2003-09-25
ES2386742T3 (es) 2012-08-28
PT1490383E (pt) 2009-05-25
AU2003218111A1 (en) 2003-09-29
AU2008249300B2 (en) 2012-08-16
ATE556084T1 (de) 2012-05-15
AU2008249300A1 (en) 2008-12-18
EP1947104B1 (en) 2012-05-02
US8173795B2 (en) 2012-05-08
DK2014671T3 (da) 2010-09-20
ATE423785T1 (de) 2009-03-15
EP1947104A3 (en) 2009-04-08
PT2014671E (pt) 2010-06-16
EP1490383A2 (en) 2004-12-29
US20120322051A1 (en) 2012-12-20
EP1947104A2 (en) 2008-07-23
EP2014671B1 (en) 2010-05-26
ES2346717T3 (es) 2010-10-19
WO2003077729A3 (en) 2004-06-03
EP1490383A4 (en) 2005-12-21
WO2003077729A9 (en) 2004-04-22
DE60332781D1 (de) 2010-07-08
ES2321498T3 (es) 2009-06-08
DE60326327D1 (de) 2009-04-09
ATE469162T1 (de) 2010-06-15
AU2003218111B8 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
DK1947104T3 (da) Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C
ATE440965T1 (de) Neue zusammensetzung und methode zur 'hot start' nukleinsäureamplifizierung
ATE432365T1 (de) Verfahren, kits und reagenzien zur nukleinsäuresequenzierung
DK1026262T3 (da) Oligonukleotidprimere til effektiv detektering af hepatitis C-virus (HCV) og fremgangsmåder til anvendelse deraf
DK1159453T3 (da) Fremgangsmåde til direkte nukleinsyresekventering
DE60230672D1 (de) Nukleinsäureanreicherung
DK1423400T3 (da) Evolution af hidtil ukendt molekylfunktion
NO20021223L (no) Fremgangsmater og sammensetninger for lineaer, isoterm amplifisering av polynukleotidsekvenser
HK1074458A1 (en) Thermostable taq polymerase fragment
ATE517194T1 (de) Zusammensetzungen zur verwendung bei der bestimmung von hämorrhagischen fieberviren
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
ATE485391T1 (de) Zusammensetzungen, methoden und testssysteme zur bestimmung der präsenz von cryptosporidium organismen in einer testprobe
DE60041912D1 (de) Polymorphe marker des lsr-gens
ATE516365T1 (de) Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer
DE60024679D1 (de) Methoden und zusammensetzungen zur detektion von spezies des mycobacterium avium-komplexes
NO20000537D0 (no) Oligonukleotidprimere for effektiv reverstranskripsjon av Hepatitis C-virus (HCV) RNA og metoder for anvendelse derav
ATE414175T1 (de) Detektion von rpob sequenzen von mycobacterium tuberculosis
ATE486932T1 (de) Thermostabile dna polymerase von archae ampullavirus abv und dessen verwendungen
ATE440153T1 (de) Verfahren und kit zur abschätzung der nebenwirkung durch eine paclitaxel-therapie